217 related articles for article (PubMed ID: 8976821)
41. Current approaches in cytoprotection: the role of amifostine (Ethyol) in altering and ameliorating toxicities in cancer therapy.
Bukowski RM
Eur J Cancer; 1996; 32A Suppl 4():S1. PubMed ID: 8976814
[No Abstract] [Full Text] [Related]
42. Amifostine and combined-modality therapeutic approaches.
Mehta MP
Semin Oncol; 1999 Apr; 26(2 Suppl 7):95-101. PubMed ID: 10348267
[TBL] [Abstract][Full Text] [Related]
43. Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector.
Spencer CM; Goa KL
Drugs; 1995 Dec; 50(6):1001-31. PubMed ID: 8612469
[TBL] [Abstract][Full Text] [Related]
44. Reducing the toxicity of anticancer therapy: new strategies.
Griggs JJ
Leuk Res; 1998 May; 22 Suppl 1():S27-33. PubMed ID: 9734697
[TBL] [Abstract][Full Text] [Related]
45. Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
Gandara DR; Wiebe VJ; Perez EA; Makuch RW; DeGregorio MW
Crit Rev Oncol Hematol; 1990; 10(4):353-65. PubMed ID: 2177606
[TBL] [Abstract][Full Text] [Related]
46. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
Thongprasert S; Chewaskulyong B
J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
[TBL] [Abstract][Full Text] [Related]
47. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
[TBL] [Abstract][Full Text] [Related]
48. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
Capizzi RL
Semin Oncol; 1999 Apr; 26(2 Suppl 7):3-21. PubMed ID: 10348255
[TBL] [Abstract][Full Text] [Related]
49. Future development of amifostine as a radioprotectant.
Werner-Wasik M
Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
[TBL] [Abstract][Full Text] [Related]
50. Future development of amifostine in cancer treatment.
Alberts DS; Bleyer WA
Semin Oncol; 1996 Aug; 23(4 Suppl 8):90-9. PubMed ID: 8783674
[TBL] [Abstract][Full Text] [Related]
51. Amifostine: is there evidence of tumor protection?
Koukourakis MI
Semin Oncol; 2003 Dec; 30(6 Suppl 18):18-30. PubMed ID: 14727237
[TBL] [Abstract][Full Text] [Related]
52. Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers J; Chaudhry V; Cavaletti G; Donehower R
Cochrane Database Syst Rev; 2007 Jan; (1):CD005228. PubMed ID: 17253547
[TBL] [Abstract][Full Text] [Related]
53. Radiotherapeutic studies with amifostine (Ethyol).
Wasserman TH
Semin Oncol; 1994 Oct; 21(5 Suppl 11):21-5. PubMed ID: 7973775
[TBL] [Abstract][Full Text] [Related]
54. Amifostine (Ethyol): dosing, administration and patient management guidelines.
Bukowski RM
Eur J Cancer; 1996; 32A Suppl 4():S46-9. PubMed ID: 8976823
[TBL] [Abstract][Full Text] [Related]
55. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
[TBL] [Abstract][Full Text] [Related]
56. Assessment of the protective effects of amifostine against cisplatin-induced toxicity.
Hussain AE; Blakley BW; Nicolas M; Balderston J
J Otolaryngol; 2003 Oct; 32(5):294-7. PubMed ID: 14974858
[TBL] [Abstract][Full Text] [Related]
57. Protective effect of amifostine against cisplatin-induced motor neuropathy in rat.
Yalcin S; Nurlu G; Orhan B; Zeybek D; Müftüoğlu S; Sarer B; Yildirim BA; Cetin E
Med Oncol; 2003; 20(2):175-80. PubMed ID: 12835521
[TBL] [Abstract][Full Text] [Related]
58. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
[TBL] [Abstract][Full Text] [Related]
59. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
Marcu LG
Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
[TBL] [Abstract][Full Text] [Related]
60. Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.
Selvaggi G; Belani CP
Semin Oncol; 1999 Apr; 26(2 Suppl 7):51-60. PubMed ID: 10348261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]